Comparison of Chemotherapy vs Chemotherapy Plus Total Hysterectomy for Women With Uterine Cancer With Distant Organ Metastasis

Yuefeng Wang; Todd Tillmanns; Noam VanderWalde; Bradley Somer; Ari VanderWalde; Lee Schwartzberg; Matthew T Ballo

doi:10.1001/jamanetworkopen.2021.18603

Comparison of Chemotherapy vs Chemotherapy Plus Total Hysterectomy for Women With Uterine Cancer With Distant Organ Metastasis

JAMA Netw Open. 2021 Jul 1;4(7):e2118603. doi: 10.1001/jamanetworkopen.2021.18603.

Authors

Yuefeng Wang¹, Todd Tillmanns², Noam VanderWalde¹, Bradley Somer³, Ari VanderWalde³, Lee Schwartzberg³, Matthew T Ballo¹

Affiliations

¹ Department of Radiation Oncology, West Cancer Center and Research Institute, Memphis, Tennessee.
² Department of Gynecologic Oncology, West Cancer Center and Research Institute, Memphis, Tennessee.
³ Department of Hematology/Oncology, West Cancer Center and Research Institute, Memphis, Tennessee.

Abstract

This cohort study evaluates the overall survival for patients with uterine cancer with distant organ metastasis treated with chemotherapy alone vs chemotherapy plus total abdominal hysterectomy.

Publication types

Comparative Study
Observational Study

MeSH terms

Adult
Aged
Antineoplastic Agents / therapeutic use*
Combined Modality Therapy
Female
Humans
Hysterectomy / methods
Hysterectomy / mortality*
Middle Aged
Neoplasm Metastasis
Propensity Score
Treatment Outcome
Uterine Neoplasms / mortality*
Uterine Neoplasms / pathology
Uterine Neoplasms / therapy*

Substances

Antineoplastic Agents